Algeria: Medicaments Containing Insulin Market 2023

Medicaments Containing Insulin Market Size in Algeria

The Algerian medicaments containing insulin market shrank modestly to $X in 2021, which is down by -4.4% against the previous year. Over the period under review, consumption recorded a mild contraction. As a result, consumption reached the peak level of $X. From 2018 to 2021, the growth of the market remained at a somewhat lower figure.

Medicaments Containing Insulin Production in Algeria

In value terms, medicaments containing insulin production contracted to $X in 2021 estimated in export price. In general, production, however, saw a noticeable downturn. The pace of growth appeared the most rapid in 2020 with an increase of 12%. Over the period under review, production hit record highs at $X in 2012; however, from 2013 to 2021, production failed to regain momentum.

Medicaments Containing Insulin Exports

Exports from Algeria

For the third consecutive year, Algeria recorded growth in shipments abroad of medicaments containing insulin but not antibiotics, which increased by 20% to X kg in 2021. In general, exports, however, continue to indicate a deep downturn. The exports peaked at X kg in 2017; however, from 2018 to 2021, the exports failed to regain momentum.

In value terms, medicaments containing insulin exports expanded notably to $X in 2021. Over the period under review, exports, however, saw a noticeable reduction. Over the period under review, the exports attained the peak figure at $X in 2017; however, from 2018 to 2021, the exports remained at a lower figure.

Exports by Country

Denmark (X kg) was the main destination for medicaments containing insulin exports from Algeria, with a approx. 50% share of total exports.

From 2017 to 2021, the average annual rate of growth in terms of volume to Denmark was relatively modest.

In value terms, Denmark ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics exports from Algeria.

From 2017 to 2021, the average annual rate of growth in terms of value to Denmark was relatively modest.

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2021, shrinking by -12.5% against the previous year. In general, the export price, however, saw buoyant growth. Over the period under review, the average export prices hit record highs at $X per ton in 2020, and then shrank in the following year.

As there is only one major export destination, the average price level is determined by prices for Denmark.

From 2017 to 2021, the rate of growth in terms of prices for Denmark amounted to 0.0% per year.

Medicaments Containing Insulin Imports

Imports into Algeria

In 2017, imports of medicaments containing insulin but not antibiotics into Algeria surged to X kg, rising by 350% against 2016 figures. Overall, imports saw a significant expansion. As a result, imports reached the peak and are likely to continue growth in the immediate term.

In value terms, medicaments containing insulin imports contracted rapidly to $X in 2017. Over the period under review, imports showed a buoyant expansion. The most prominent rate of growth was recorded in 2014 with an increase of 246%. Over the period under review, imports attained the maximum at $X in 2016, and then dropped significantly in the following year.

Imports by Country

In 2017, Germany (X kg) was the main medicaments containing insulin supplier to Algeria, accounting for a 92% share of total imports. Moreover, medicaments containing insulin imports from Germany exceeded the figures recorded by the second-largest supplier, Denmark (X kg), more than tenfold.

From 2012 to 2017, the average annual growth rate of volume from Germany was relatively modest.

In value terms, Germany ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Algeria, comprising 91% of total imports. The second position in the ranking was held by Denmark ($X), with an 8.6% share of total imports.

From 2012 to 2017, the average annual rate of growth in terms of value from Germany was relatively modest.

Import Prices by Country

The average medicaments containing insulin import price stood at $X per ton in 2017, with a decrease of -96.4% against the previous year. Overall, the import price recorded a significant decrease. The pace of growth was the most pronounced in 2014 an increase of 92%. Over the period under review, average import prices reached the peak figure at $X per ton in 2016, and then fell significantly in the following year.

Average prices varied noticeably amongst the major supplying countries. In 2017, amid the top importers, the country with the highest price was Denmark ($X per ton), while the price for Germany amounted to $X per ton.

From 2013 to 2017, the most notable rate of growth in terms of prices was attained by Denmark (0.0%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Market Intelligence Platform

Frequently Asked Questions (FAQ) :